SCHEMBL965784

SCHEMBL965784

C=CCCCCC1=NCCO1

nearest known ligand 0.61

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.35
USP2 O75604 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
LMNA P02545 2/20 0.34
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8672240 0.98 TDP1 (0.38) TDP1USP2ALDH1A1HPGDLMNA
SCHEMBL20752971 0.98 TDP1 (0.38) TDP1USP2ALDH1A1HPGDLMNA
SCHEMBL181528 0.86
SCHEMBL351887 0.84 ADRA2A (0.32)
SCHEMBL10410293 0.82 ADRA2A (0.32)
SCHEMBL381129 0.82 ADRA2A (0.32)
SCHEMBL9003861 0.82 ADRA2A (0.32)
SCHEMBL471908 0.82 ADRA2A (0.32)
SCHEMBL27490832 0.82 ADRA2A (0.32)
SCHEMBL27966021 0.82 ADRA2A (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11111320-B2 Addition-fragmentation oligomers 3M INNOVATIVE PROPERTIES COMPANY (US) 2021-09-07 US disclosed
CN-107406723-B Addition-fragmentation oligomers 3M创新有限公司 2021-05-07 CN disclosed
EP-2675783-B1 ADDITION-FRAGMENTATION AGENTS 3M INNOVATIVE PROPERTIES CO (US) 2020-04-22 EP disclosed
EP-3259323-B1 ADDITION-FRAGMENTATION OLIGOMERS 3M INNOVATIVE PROPERTIES CO (US) 2020-02-26 EP disclosed
US-20200031961-A1 ADDITION-FRAGMENTATION OLIGOMERS 3M INNOVATIVE PROPERTIES CO (US) 2020-01-30 US disclosed
US-10479848-B2 Addition-fragmentation oligomers 3M INNOVATIVE PROPERTIES COMPANY (US) 2019-11-19 US disclosed
US-10370322-B2 Addition-fragmentation agents 3M INNOVATIVE PROPERTIES COMPANY (US) 2019-08-06 US disclosed
EP-3502092-A1 ADDITION-FRAGMENTATION AGENTS 3M Innovative Properties Company (US) 2019-06-26 EP disclosed
EP-2931756-B1 ADDITION-FRAGMENTATION OLIGOMERS 3M INNOVATIVE PROPERTIES CO (US) 2018-08-08 EP disclosed
EP-3058014-B1 ALLYL DISULFIDE-CONTAINING ADDITION-FRAGMENTATION OLIGOMERS 3M INNOVATIVE PROPERTIES CO (US) 2018-06-20 EP disclosed
WO-2003015720-A1 HARDENABLE SELF-SUPPORTING STRUCTURES AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-02-27 WO disclosed
WO-2002102909-A1 REACTIVE OLIGOMERS 3M INNOVATIVE PROPERTIES COMPANY (US) 2002-12-27 WO disclosed
US-20020132927-A1 Pressure sensitive adhesives possessing high load bearing capability 3M INNOVATIVE PROPERTIES COMPANY 2002-09-19 US disclosed
US-6448337-B1 CURABLE SYRUP COMPRISING DUAL POLYMERS CONTAINING PENDANT INTERREACTIVE GROUPS, FREE RADICAL POLYMERIZABLE SOLVENT MONOMER AND PHOTOINITIATOR; BALANCED ADHESIVE AND COHESIVE CHARACTERISTICS 3M INNOVATIVE PROPERTIES COMPANY 2002-09-10 US disclosed
EP-1230315-A1 PRESSURE SENSITIVE ADHESIVES POSSESSING HIGH LOAD BEARING CAPABILITY 3M Innovative Properties Company (US) 2002-08-14 EP disclosed
WO-2002038694-A1 PRESSURE SENSITIVE ADHESIVES POSSESSING HIGH LOAD BEARING CAPABILITY 3M INNOVATIVE PROPERTIES COMPANY (US) 2002-05-16 WO disclosed
EP-0808348-B1 CROSS-LINKABLE PRESSURE SENSITIVE ADHESIVE AND PROCESS FOR THE PRODUCTION OF AN ARTICLE COATED WITH A CROSSLINKED PRESSURE SENSITIVE ADHESIVE MINNESOTA MINING & MFG (US) 1999-05-06 EP disclosed
US-5741543-A CONTAINING UNSATURATED MONOMERS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1998-04-21 US disclosed
EP-0808348-A1 PROCESS FOR THE PRODUCTION OF AN ARTICLE COATED WITH A CROSSLINKED PRESSURE SENSITIVE ADHESIVE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-11-26 EP disclosed
WO-1996024644-A1 PROCESS FOR THE PRODUCTION OF AN ARTICLE COATED WITH A CROSSLINKED PRESSURE SENSITIVE ADHESIVE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1996-08-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10479848-B2 Addition-fragmentation oligomers ECPAS, ITGA8, NBAS TDP1 1001/4885USP2 2205/4885ALDH1A1 2212/4885
US-10370322-B2 Addition-fragmentation agents NR4A1, PARP14, MTX1 TDP1 2447/4885USP2 4284/4885ALDH1A1 3630/4885
US-20200031961-A1 ADDITION-FRAGMENTATION OLIGOMERS ECPAS, ITGA8, NBAS TDP1 1001/4885USP2 2205/4885ALDH1A1 2212/4885
US-11111320-B2 Addition-fragmentation oligomers ECPAS, ITGA8, NBAS TDP1 1001/4885USP2 2205/4885ALDH1A1 2212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.